TY - JOUR AU - Cubbon, R. M. AU - Adams, B. AU - Rajwani, A. AU - Mercer, B. N. AU - Patel, P. A. AU - Gherardi, G. PY - 2013 DA - 2013// TI - Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology JO - Diab Vasc Dis Res. VL - 10 UR - https://doi.org/10.1177/1479164112471064 DO - 10.1177/1479164112471064 ID - Cubbon2013 ER - TY - STD TI - International Diabetes Federation: IDF diabetes atlas seventh edition. 2015. ID - ref2 ER - TY - STD TI - International Diabetes Federation: Diabetes and cardiovascular disease. 2016. ID - ref3 ER - TY - JOUR AU - Ezekowitz, J. A. AU - Kaul, P. AU - Bakal, J. A. AU - Quan, H. AU - McAlister, F. A. PY - 2011 DA - 2011// TI - Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? JO - Eur J Heart Fail VL - 13 UR - https://doi.org/10.1093/eurjhf/hfq185 DO - 10.1093/eurjhf/hfq185 ID - Ezekowitz2011 ER - TY - JOUR AU - Shah, A. D. AU - Langenberg, C. AU - Rapsomaniki, E. AU - Denaxas, S. AU - Pujades-Rodriguez, M. AU - Gale, C. P. PY - 2015 DA - 2015// TI - Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people JO - Lancet Diabetes Endocrinol. VL - 3 UR - https://doi.org/10.1016/S2213-8587(14)70219-0 DO - 10.1016/S2213-8587(14)70219-0 ID - Shah2015 ER - TY - JOUR AU - Mathers, C. D. AU - Loncar, D. PY - 2006 DA - 2006// TI - Projections of global mortality and burden of disease from 2002 to 2030 JO - PLoS Med. VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030442 DO - 10.1371/journal.pmed.0030442 ID - Mathers2006 ER - TY - JOUR AU - Braunwald, E. PY - 1997 DA - 1997// TI - Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities JO - N Engl J Med VL - 337 UR - https://doi.org/10.1056/NEJM199711063371906 DO - 10.1056/NEJM199711063371906 ID - Braunwald1997 ER - TY - JOUR AU - Nathan, D. M. AU - Genuth, S. AU - Lachin, J. AU - Cleary, P. AU - Crofford, O. AU - Davis, M. PY - 1993 DA - 1993// TI - The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes control and complications trial research group JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309303291401 DO - 10.1056/NEJM199309303291401 ID - Nathan1993 ER - TY - JOUR AU - Nathan, D. M. AU - Cleary, P. A. AU - Backlund, J. Y. AU - Genuth, S. M. AU - Lachin, J. M. AU - Orchard, T. J. PY - 2005 DA - 2005// TI - Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa052187 DO - 10.1056/NEJMoa052187 ID - Nathan2005 ER - TY - JOUR PY - 2008 DA - 2008// TI - Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0802987 DO - 10.1056/NEJMoa0802987 ID - ref10 ER - TY - JOUR AU - King, P. AU - Peacock, I. AU - Donnelly, R. PY - 1999 DA - 1999// TI - The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes JO - Br J Clin Pharmacol VL - 48 UR - https://doi.org/10.1046/j.1365-2125.1999.00092.x DO - 10.1046/j.1365-2125.1999.00092.x ID - King1999 ER - TY - JOUR AU - Gerstein, H. C. AU - Miller, M. E. AU - Byington, R. P. AU - Bigger, J. T. AU - Buse, J. B. AU - Cushman, W. C. PY - 2008 DA - 2008// TI - Effects of intensive glucose lowering in type 2 diabetes JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0802743 DO - 10.1056/NEJMoa0802743 ID - Gerstein2008 ER - TY - JOUR AU - Schnell, O. AU - Rydén, L. AU - Standl, E. AU - Ceriello, A. PY - 2017 DA - 2017// TI - Updates on cardiovascular outcome trials in diabetes JO - Cardiovasc Diabetol. VL - 16 UR - https://doi.org/10.1186/s12933-017-0610-y DO - 10.1186/s12933-017-0610-y ID - Schnell2017 ER - TY - STD TI - Food and Drug Administration: Guidance for industry diabetes mellitus—evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. 2008. ID - ref14 ER - TY - JOUR AU - Marso, S. P. AU - Bain, S. C. AU - Consoli, A. AU - Eliaschewitz, F. G. AU - Jódar, E. AU - Leiter, L. A. PY - 2016 DA - 2016// TI - Semaglutide and cardiovascular outcomes in patients with type 2 diabetes JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1607141 DO - 10.1056/NEJMoa1607141 ID - Marso2016 ER - TY - JOUR AU - Marso, S. P. AU - Daniels, G. H. AU - Brown-Frandsen, K. AU - Kristensen, P. AU - Mann, J. F. AU - Nauck, M. A. PY - 2016 DA - 2016// TI - Liraglutide and cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1603827 DO - 10.1056/NEJMoa1603827 ID - Marso2016 ER - TY - JOUR AU - Sanon, V. P. AU - Patel, S. AU - Sanon, S. AU - Rodriguez, R. AU - Pham, S. V. AU - Chilton, R. PY - 2017 DA - 2017// TI - Differential cardiovascular profiles of sodium–glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin JO - Ther Clin Risk Manag VL - 3 UR - https://doi.org/10.2147/TCRM.S97619 DO - 10.2147/TCRM.S97619 ID - Sanon2017 ER - TY - JOUR AU - Trujillo, J. M. AU - Nuffer, W. A. PY - 2017 DA - 2017// TI - Impact of sodium–glucose cotransporter 2 inhibitors on nonglycaemic outcomes in patients with type 2 diabetes JO - Pharmacotherapy. VL - 37 UR - https://doi.org/10.1002/phar.1903 DO - 10.1002/phar.1903 ID - Trujillo2017 ER - TY - JOUR PY - 2018 DA - 2018// TI - Cardiovascular disease and risk management: standards of medical care in diabetes-2018 JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dc18-S009 DO - 10.2337/dc18-S009 ID - ref19 ER - TY - JOUR PY - 2017 DA - 2017// TI - Introduction JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc17-S001 DO - 10.2337/dc17-S001 ID - ref20 ER - TY - JOUR AU - Halperin, J. L. AU - Levine, G. N. AU - Al-Khatib, S. M. AU - Birtcher, K. K. AU - Bozkurt, B. AU - Brindis, R. G. PY - 2016 DA - 2016// TI - Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines JO - J Am Coll Cardiol VL - 67 UR - https://doi.org/10.1016/j.jacc.2015.09.001 DO - 10.1016/j.jacc.2015.09.001 ID - Halperin2016 ER - TY - JOUR AU - Udell, J. A. AU - Bhatt, D. L. AU - Braunwald, E. AU - Cavender, M. A. AU - Mosenzon, O. AU - Steg, P. G. PY - 2015 DA - 2015// TI - Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial JO - Diabetes Care VL - 38 ID - Udell2015 ER - TY - JOUR AU - McGuire, D. K. AU - Alexander, J. H. AU - Johansen, O. E. AU - Perkovic, V. AU - Rosenstock, J. AU - Cooper, M. E. PY - 2019 DA - 2019// TI - Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA JO - Circulation VL - 139 UR - https://doi.org/10.1161/CIRCULATIONAHA.118.038352 DO - 10.1161/CIRCULATIONAHA.118.038352 ID - McGuire2019 ER - TY - JOUR AU - Jarolim, P. AU - White, W. B. AU - Cannon, C. P. AU - Gao, Q. AU - Morrow, D. A. PY - 2018 DA - 2018// TI - Serial measurement of natriuretic peptides and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE trial JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dc18-0109 DO - 10.2337/dc18-0109 ID - Jarolim2018 ER - TY - JOUR AU - Green, J. B. AU - Bethel, M. A. AU - Armstrong, P. W. AU - Buse, J. B. AU - Engel, S. S. AU - Garg, J. PY - 2015 DA - 2015// TI - Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1501352 DO - 10.1056/NEJMoa1501352 ID - Green2015 ER - TY - JOUR AU - Zinman, B. AU - Wanner, C. AU - Lachin, J. M. AU - Fitchett, D. AU - Bluhmki, E. AU - Hantel, S. PY - 2015 DA - 2015// TI - Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504720 DO - 10.1056/NEJMoa1504720 ID - Zinman2015 ER - TY - JOUR AU - Neal, B. AU - Perkovic, V. AU - Mahaffey, K. W. AU - Zeeuw, D. AU - Fulcher, G. AU - Erondu, N. PY - 2017 DA - 2017// TI - Canagliflozin and cardiovascular and renal events in type 2 diabetes JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1611925 DO - 10.1056/NEJMoa1611925 ID - Neal2017 ER - TY - JOUR AU - Wiviott, S. D. AU - Raz, I. AU - Bonaca, M. P. AU - Mosenzon, O. AU - Kato, E. T. AU - Cahn, A. PY - 2019 DA - 2019// TI - Dapagliflozin and cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 380 UR - https://doi.org/10.1056/NEJMoa1812389 DO - 10.1056/NEJMoa1812389 ID - Wiviott2019 ER - TY - JOUR AU - Hernandez, A. F. AU - Green, J. B. AU - Janmohamed, S. AU - D’Agostino, R. B. AU - Granger, C. B. AU - Jones, N. P. PY - 2018 DA - 2018// TI - Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial JO - Lancet VL - 392 UR - https://doi.org/10.1016/S0140-6736(18)32261-X DO - 10.1016/S0140-6736(18)32261-X ID - Hernandez2018 ER - TY - JOUR AU - Pfeffer, M. A. AU - Claggett, B. AU - Diaz, R. AU - Dickstein, K. AU - Gerstein, H. C. AU - Køber, L. V. PY - 2015 DA - 2015// TI - Lixisenatide in patients with type 2 diabetes and acute coronary syndrome JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1509225 DO - 10.1056/NEJMoa1509225 ID - Pfeffer2015 ER - TY - JOUR AU - Holman, R. R. AU - Bethel, M. A. AU - Mentz, R. J. AU - Thompson, V. P. AU - Lokhnygina, Y. AU - Buse, J. B. PY - 2017 DA - 2017// TI - Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1612917 DO - 10.1056/NEJMoa1612917 ID - Holman2017 ER - TY - JOUR AU - Dormandy, J. A. AU - Charbonnel, B. AU - Eckland, D. J. AU - Erdmann, E. AU - Massi-Benedetti, M. AU - Moules, I. K. PY - 2005 DA - 2005// TI - Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67528-9 DO - 10.1016/S0140-6736(05)67528-9 ID - Dormandy2005 ER - TY - JOUR AU - Gerstein, H. C. AU - Bosch, J. AU - Dagenais, G. R. AU - Díaz, R. AU - Jung, H. AU - Maggioni, A. P. PY - 2012 DA - 2012// TI - Basal insulin and cardiovascular and other outcomes in dysglycemia JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1203858 DO - 10.1056/NEJMoa1203858 ID - Gerstein2012 ER - TY - JOUR AU - Kernan, W. N. AU - Viscoli, C. M. AU - Furie, K. L. AU - Young, L. H. AU - Inzucchi, S. E. AU - Gorman, M. PY - 2016 DA - 2016// TI - Pioglitazone after ischemic stroke or transient ischemic attack JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1506930 DO - 10.1056/NEJMoa1506930 ID - Kernan2016 ER - TY - JOUR AU - Marso, S. P. AU - McGuire, D. K. AU - Zinman, B. AU - Poulter, N. R. AU - Emerson, S. S. AU - Pieber, T. R. PY - 2017 DA - 2017// TI - Efficacy and safety of degludec versus glargine in type 2 diabetes JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1615692 DO - 10.1056/NEJMoa1615692 ID - Marso2017 ER - TY - JOUR AU - Holman, R. R. AU - Coleman, R. L. AU - Chan, J. C. N. AU - Chiasson, J. L. AU - Feng, H. AU - Ge, J. PY - 2017 DA - 2017// TI - Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial JO - Lancet Diabetes Endocrinol. VL - 5 UR - https://doi.org/10.1016/S2213-8587(17)30309-1 DO - 10.1016/S2213-8587(17)30309-1 ID - Holman2017 ER - TY - JOUR AU - Marx, N. AU - McGuire, D. K. AU - Perkovic, V. AU - Woerle, H. J. AU - Broedl, U. C. AU - Eynatten, M. PY - 2017 DA - 2017// TI - Composite primary end points in cardiovascular outcomes trials involving type 2 diabetes patients: should unstable angina be included in the primary end point? JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc17-0068 DO - 10.2337/dc17-0068 ID - Marx2017 ER - TY - JOUR AU - Cefalu, W. T. AU - Kaul, S. AU - Gerstein, H. C. AU - Holman, R. R. AU - Zinman, B. AU - Skyler, J. S. PY - 2018 DA - 2018// TI - Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors’ expert forum JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dci17-0057 DO - 10.2337/dci17-0057 ID - Cefalu2018 ER - TY - STD TI - U.S. Department of Health and Human Services; Final guidance for industry: guidance for industry: diabetes mellitus—evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. U.S. Department of Health and Human Resources; 2008. http://tinyurl.com/lkwfp5. Accessed 6 Aug 2014. UR - http://tinyurl.com/lkwfp5 ID - ref39 ER - TY - JOUR AU - Raveendran, A. V. AU - Chacko, E. C. AU - Pappachan, J. M. PY - 2018 DA - 2018// TI - Non-pharmacological treatment options in the management of diabetes mellitus JO - Eur Endocrinol. VL - 14 UR - https://doi.org/10.17925/EE.2018.14.2.31 DO - 10.17925/EE.2018.14.2.31 ID - Raveendran2018 ER - TY - JOUR PY - 2018 DA - 2018// TI - Lifestyle management: standards of medical care in diabetes—2018 JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dc18-S004 DO - 10.2337/dc18-S004 ID - ref41 ER - TY - JOUR AU - Wing, R. R. AU - Bolin, P. AU - Brancati, F. L. AU - Bray, G. A. AU - Clark, J. M. AU - Coday, M. PY - 2013 DA - 2013// TI - Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1212914 DO - 10.1056/NEJMoa1212914 ID - Wing2013 ER - TY - JOUR AU - Thomas, D. AU - Elliott, E. J. PY - 2009 DA - 2009// TI - Low glycaemic index, or low glycaemic load, diets for diabetes mellitus JO - Cochrane Database Syst Rev. UR - https://doi.org/10.1002/14651858.CD006296.pub2 DO - 10.1002/14651858.CD006296.pub2 ID - Thomas2009 ER - TY - JOUR AU - Ajala, O. AU - English, P. AU - Pinkney, J. PY - 2013 DA - 2013// TI - Systematic review and metaanalysis of different dietary approaches to the management of type 2 diabetes JO - Am J Clin Nutr VL - 97 UR - https://doi.org/10.3945/ajcn.112.042457 DO - 10.3945/ajcn.112.042457 ID - Ajala2013 ER - TY - JOUR AU - Buyken, A. E. AU - Goletzke, J. AU - Joslowski, G. AU - Felbick, A. AU - Cheng, G. AU - Herder, C. PY - 2014 DA - 2014// TI - Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies JO - Am J Clin Nutr VL - 99 UR - https://doi.org/10.3945/ajcn.113.074252 DO - 10.3945/ajcn.113.074252 ID - Buyken2014 ER - TY - JOUR AU - Choi, Y. AU - Giovannucci, E. AU - Lee, J. E. PY - 2012 DA - 2012// TI - Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a meta-analysis JO - Br J Nutr VL - 108 UR - https://doi.org/10.1017/S0007114512003984 DO - 10.1017/S0007114512003984 ID - Choi2012 ER - TY - JOUR AU - Davies, M. J. AU - Dalessio, D. A. AU - Fradkin, J. AU - Kernan, W. N. AU - Mathieu, C. AU - Mingrone, G. PY - 2018 DA - 2018// TI - Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) JO - Diabetologia VL - 61 UR - https://doi.org/10.1007/s00125-018-4729-5 DO - 10.1007/s00125-018-4729-5 ID - Davies2018 ER - TY - JOUR AU - Kumari, G. AU - Singh, V. AU - Jhingan, A. K. AU - Chhajer, B. AU - Dahiya, S. PY - 2018 DA - 2018// TI - Effectiveness of lifestyle modification counseling on glycemic control in type 2 diabetes mellitus patients JO - Curr Res Nutr Food Sci. VL - 6 ID - Kumari2018 ER - TY - STD TI - Food and Drug Administration: Drug safety communications. FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. 2016. ID - ref49 ER - TY - JOUR AU - Schnell, O. AU - Rydén, L. AU - Standl, E. AU - Ceriello, A. PY - 2016 DA - 2016// TI - Current perspectives on cardiovascular outcome trials in diabetes JO - Cardiovasc Diabetol. VL - 15 ID - Schnell2016 ER - TY - JOUR AU - Boussageon, R. AU - Supper, I. AU - Bejan-Angoulvant, T. AU - Kellou, N. AU - Cucherat, M. AU - Boissel, J. P. PY - 2012 DA - 2012// TI - Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials JO - PLoS Med. VL - 9 UR - https://doi.org/10.1371/journal.pmed.1001204 DO - 10.1371/journal.pmed.1001204 ID - Boussageon2012 ER - TY - JOUR AU - Griffin, S. J. AU - Leaver, J. K. AU - Irving, G. J. PY - 2017 DA - 2017// TI - Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes JO - Diabetologia VL - 60 UR - https://doi.org/10.1007/s00125-017-4337-9 DO - 10.1007/s00125-017-4337-9 ID - Griffin2017 ER - TY - JOUR AU - Harrington, J. L. AU - Albuquerque Rocha, N. AU - Patel, K. V. AU - Verma, S. AU - McGuire, D. K. PY - 2018 DA - 2018// TI - Should metformin remain first-line medical therapy for patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease? An alternative approach JO - Curr Diab Rep. VL - 18 UR - https://doi.org/10.1007/s11892-018-1035-z DO - 10.1007/s11892-018-1035-z ID - Harrington2018 ER - TY - JOUR AU - Gerstein, H. C. AU - Colhoun, H. M. AU - Dagenais, G. R. AU - Diaz, R. AU - Lakshmanan, M. AU - Pais, P. PY - 2019 DA - 2019// TI - Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial JO - Lancet UR - https://doi.org/10.1016/S0140-6736(19)31150-X DO - 10.1016/S0140-6736(19)31150-X ID - Gerstein2019 ER - TY - JOUR AU - Imprialos, K. P. AU - Boutari, C. AU - Stavropoulos, K. AU - Doumas, M. AU - Karagiannis, A. I. PY - 2017 DA - 2017// TI - Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality? JO - J Neurol Neurosurg Psychiatry VL - 88 UR - https://doi.org/10.1136/jnnp-2016-314704 DO - 10.1136/jnnp-2016-314704 ID - Imprialos2017 ER - TY - JOUR AU - Khouri, C. AU - Cracowski, J. L. AU - Roustit, M. PY - 2018 DA - 2018// TI - SGLT-2 inhibitors and the risk of lower-limb amputation: is this a class effect? JO - Diabetes Obes Metab VL - 20 UR - https://doi.org/10.1111/dom.13255 DO - 10.1111/dom.13255 ID - Khouri2018 ER - TY - JOUR AU - Kosiborod, M. AU - Cavender, M. A. AU - Fu, A. Z. AU - Wilding, J. P. AU - Khunti, K. AU - Holl, R. W. PY - 2017 DA - 2017// TI - Lower risk of heart failure and death in patients initiated on sodium–glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (Comparative effectiveness of cardiovascular outcomes in new users of sodium–glucose cotransporter-2 inhibitors) JO - Circulation VL - 136 UR - https://doi.org/10.1161/CIRCULATIONAHA.117.029190 DO - 10.1161/CIRCULATIONAHA.117.029190 ID - Kosiborod2017 ER - TY - JOUR AU - Abdul-Ghani, M. A. AU - Puckett, C. AU - Triplitt, C. AU - Maggs, D. AU - Adams, J. AU - Cersosimo, E. PY - 2015 DA - 2015// TI - Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial JO - Diabetes Obes Metab VL - 17 UR - https://doi.org/10.1111/dom.12417 DO - 10.1111/dom.12417 ID - Abdul-Ghani2015 ER - TY - JOUR AU - Abdul-Ghani, M. AU - Migahid, O. AU - Megahed, A. AU - Adams, J. AU - Triplitt, C. AU - DeFronzo, R. A. PY - 2017 DA - 2017// TI - Combination therapy with exenatide plus pioglitazone versus basal/bolus insulin in patients with poorly controlled type 2 diabetes on sulfonylurea plus metformin: the Qatar study JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc16-1738 DO - 10.2337/dc16-1738 ID - Abdul-Ghani2017 ER - TY - JOUR AU - Defronzo, R. A. AU - Tripathy, D. AU - Schwenke, D. C. AU - Banerji, M. AU - Bray, G. A. AU - Buchanan, T. A. PY - 2013 DA - 2013// TI - Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates JO - Diabetes VL - 62 UR - https://doi.org/10.2337/db13-0265 DO - 10.2337/db13-0265 ID - Defronzo2013 ER - TY - STD TI - Onglyza (package insert). Wilmington, DE: AstraZeneca Pharmaceuticals; 2017. ID - ref61 ER - TY - STD TI - Nesina (package insert). Deerfield, IL: Takeda Pharmaceuticals America; 2016. ID - ref62 ER - TY - JOUR AU - Scheen, A. J. PY - 2010 DA - 2010// TI - NAVIGATOR: a trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide JO - Rev Med Liege VL - 65 ID - Scheen2010 ER - TY - JOUR AU - Azoulay, L. AU - Suissa, S. PY - 2017 DA - 2017// TI - Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc16-1943 DO - 10.2337/dc16-1943 ID - Azoulay2017 ER - TY - STD TI - Medscape Registry: Medscape news: https://www.medscape.com/viewarticle/904373. Accessed 3 May 2019. UR - https://www.medscape.com/viewarticle/904373 ID - ref65 ER - TY - JOUR AU - Ceriello, A. AU - Novials, A. AU - Canivell, S. AU - Sala, L. AU - Pujadas, G. AU - Esposito, K. PY - 2014 DA - 2014// TI - Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc13-2618 DO - 10.2337/dc13-2618 ID - Ceriello2014 ER - TY - JOUR AU - Aravindhan, K. AU - Bao, W. AU - Harpel, M. R. AU - Willette, R. N. AU - Lepore, J. J. AU - Jucker, B. M. PY - 2015 DA - 2015// TI - Cardioprotection resulting from glucagon-like peptide-1 administration involves shifting metabolic substrate utilization to increase energy efficiency in the rat heart JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0130894 DO - 10.1371/journal.pone.0130894 ID - Aravindhan2015 ER - TY - JOUR AU - Panjwani, N. AU - Mulvihill, E. E. AU - Longuet, C. AU - Yusta, B. AU - Campbell, J. E. AU - Brown, T. J. PY - 2013 DA - 2013// TI - GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(−/−) mice JO - Endocrinology VL - 154 UR - https://doi.org/10.1210/en.2012-1937 DO - 10.1210/en.2012-1937 ID - Panjwani2013 ER - TY - JOUR AU - Rieg, T. AU - Gerasimova, M. AU - Murray, F. AU - Masuda, T. AU - Tang, T. AU - Rose, M. PY - 2012 DA - 2012// TI - Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice JO - Am J Physiol Renal Physiol VL - 303 UR - https://doi.org/10.1152/ajprenal.00259.2012 DO - 10.1152/ajprenal.00259.2012 ID - Rieg2012 ER - TY - JOUR AU - Hallow, K. M. AU - Helmlinger, G. AU - Greasley, P. J. AU - McMurray, J. J. V. AU - Boulton, D. W. PY - 2018 DA - 2018// TI - Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis JO - Diabetes Obes Metab VL - 20 UR - https://doi.org/10.1111/dom.13126 DO - 10.1111/dom.13126 ID - Hallow2018 ER - TY - JOUR AU - Karg, M. V. AU - Bosch, A. AU - Kannenkeril, D. AU - Striepe, K. AU - Ott, C. AU - Schneider, M. P. PY - 2018 DA - 2018// TI - SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial JO - Cardiovasc Diabetol. VL - 17 UR - https://doi.org/10.1186/s12933-017-0654-z DO - 10.1186/s12933-017-0654-z ID - Karg2018 ER - TY - JOUR AU - Mudaliar, S. AU - Alloju, S. AU - Henry, R. R. PY - 2016 DA - 2016// TI - Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis JO - Diabetes Care VL - 39 UR - https://doi.org/10.2337/dc16-0542 DO - 10.2337/dc16-0542 ID - Mudaliar2016 ER - TY - JOUR AU - Lopaschuk, G. D. AU - Ussher, J. R. AU - Folmes, C. D. AU - Jaswal, J. S. AU - Stanley, W. C. PY - 2010 DA - 2010// TI - Myocardial fatty acid metabolism in health and disease JO - Physiol Rev VL - 90 UR - https://doi.org/10.1152/physrev.00015.2009 DO - 10.1152/physrev.00015.2009 ID - Lopaschuk2010 ER - TY - JOUR AU - Packer, M. PY - 2018 DA - 2018// TI - Do sodium–glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis JO - Diabetes Obes Metab VL - 20 UR - https://doi.org/10.1111/dom.13229 DO - 10.1111/dom.13229 ID - Packer2018 ER - TY - JOUR AU - Garvey, W. T. AU - Gaal, L. AU - Leiter, L. A. AU - Vijapurkar, U. AU - List, J. AU - Cuddihy, R. PY - 2018 DA - 2018// TI - Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes JO - Metabolism. VL - 85 UR - https://doi.org/10.1016/j.metabol.2018.02.002 DO - 10.1016/j.metabol.2018.02.002 ID - Garvey2018 ER - TY - JOUR AU - Lee, T. M. AU - Chang, N. C. AU - Lin, S. Z. PY - 2017 DA - 2017// TI - Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts JO - Free Radic Biol Med. VL - 104 UR - https://doi.org/10.1016/j.freeradbiomed.2017.01.035 DO - 10.1016/j.freeradbiomed.2017.01.035 ID - Lee2017 ER - TY - JOUR AU - Verma, S. AU - Jüni, P. AU - Mazer, C. D. PY - 2019 DA - 2019// TI - Pump, pipes, and filter: do SGLT2 inhibitors cover it all? JO - Lancet VL - 393 UR - https://doi.org/10.1016/S0140-6736(18)32824-1 DO - 10.1016/S0140-6736(18)32824-1 ID - Verma2019 ER - TY - JOUR AU - Zelniker, T. A. AU - Wiviott, S. D. AU - Raz, I. AU - Im, K. AU - Goodrich, E. L. AU - Bonaca, M. P. PY - 2019 DA - 2019// TI - SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials JO - Lancet VL - 393 UR - https://doi.org/10.1016/S0140-6736(18)32590-X DO - 10.1016/S0140-6736(18)32590-X ID - Zelniker2019 ER - TY - JOUR AU - Damman, K. AU - Testani, J. M. PY - 2015 DA - 2015// TI - The kidney in heart failure: an update JO - Eur Heart J VL - 36 UR - https://doi.org/10.1093/eurheartj/ehv010 DO - 10.1093/eurheartj/ehv010 ID - Damman2015 ER - TY - JOUR AU - Damman, K. AU - Tang, W. H. AU - Felker, G. M. AU - Lassus, J. AU - Zannad, F. AU - Krum, H. PY - 2014 DA - 2014// TI - Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2013.11.031 DO - 10.1016/j.jacc.2013.11.031 ID - Damman2014 ER - TY - JOUR AU - Andrianesis, V. AU - Glykofridi, S. AU - Doupis, J. PY - 2016 DA - 2016// TI - The renal effects of SGLT2 inhibitors and a mini-review of the literature JO - Ther Adv Endocrinol Metab. VL - 7 UR - https://doi.org/10.1177/2042018816676239 DO - 10.1177/2042018816676239 ID - Andrianesis2016 ER - TY - JOUR AU - Jorsal, A. AU - Kistorp, C. AU - Holmager, P. AU - Tougaard, R. S. AU - Nielsen, R. AU - Hänselmann, A. PY - 2017 DA - 2017// TI - Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre, double-blind, randomised, placebo-controlled trial JO - Eur J Heart Fail VL - 19 UR - https://doi.org/10.1002/ejhf.657 DO - 10.1002/ejhf.657 ID - Jorsal2017 ER - TY - JOUR AU - Margulies, K. B. AU - Hernandez, A. F. AU - Redfield, M. M. AU - Givertz, M. M. AU - Oliveira, G. H. AU - Cole, R. PY - 2016 DA - 2016// TI - Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial JO - JAMA VL - 316 UR - https://doi.org/10.1001/jama.2016.10260 DO - 10.1001/jama.2016.10260 ID - Margulies2016 ER - TY - STD TI - American Heart Association. Annual meeting 2018; EMPA-HEART shows benefit of empagliflozin on LV remodelling in diabetes patients. American Heart Association. 2018. https://www.acc.org/latest-in-cardiology/articles/2018/11/07/16/03/sun-1145am-empa-heart-cardiolink-6-aha-2018. Accessed 3 May 2019. UR - https://www.acc.org/latest-in-cardiology/articles/2018/11/07/16/03/sun-1145am-empa-heart-cardiolink-6-aha-2018 ID - ref84 ER - TY - JOUR AU - Li, Y. AU - Ryu, C. AU - Munie, M. AU - Noorulla, S. AU - Rana, S. AU - Edwards, P. PY - 2018 DA - 2018// TI - Association of metformin treatment with reduced severity of diabetic retinopathy in type 2 diabetic patients JO - J Diabetes Res. VL - 2018 ID - Li2018 ER - TY - STD TI - American Diabetes Association updates on diabetic retinopathy 2019. American Diabetes Association. 2019. ID - ref86 ER - TY - JOUR AU - Ott, C. AU - Jumar, A. AU - Striepe, K. AU - Friedrich, S. AU - Karg, M. V. AU - Bramlage, P. PY - 2017 DA - 2017// TI - A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation JO - Cardiovasc Diabetol. VL - 16 ID - Ott2017 ER - TY - JOUR AU - Inzucchi, S. E. AU - Wanner, C. AU - Hehnke, U. AU - Zwiener, I. AU - Kaspers, S. AU - Clark, D. PY - 2019 DA - 2019// TI - Retinopathy outcomes with empagliflozin versus placebo in the EMPA-REG outcome trial JO - Diabetes Care VL - 42 UR - https://doi.org/10.2337/dc18-1355 DO - 10.2337/dc18-1355 ID - Inzucchi2019 ER - TY - JOUR AU - Muskiet, M. H. A. AU - Baar, M. J. B. AU - Scholtes, R. A. AU - Raalte, D. H. PY - 2018 DA - 2018// TI - Renal outcomes in CVOTs: keep calm and carry on JO - Lancet Diabetes Endocrinol. VL - 6 UR - https://doi.org/10.1016/S2213-8587(18)30195-5 DO - 10.1016/S2213-8587(18)30195-5 ID - Muskiet2018 ER - TY - JOUR AU - Tuttle, K. R. AU - Bakris, G. L. AU - Bilous, R. W. AU - Chiang, J. L. AU - Boer, I. H. AU - Goldstein-Fuchs, J. PY - 2014 DA - 2014// TI - Diabetic kidney disease: a report from an ADA Consensus Conference JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc14-1296 DO - 10.2337/dc14-1296 ID - Tuttle2014 ER - TY - JOUR AU - Cefalu, W. T. AU - Leiter, L. A. AU - Yoon, K. H. AU - Arias, P. AU - Niskanen, L. AU - Xie, J. PY - 2013 DA - 2013// TI - Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60683-2 DO - 10.1016/S0140-6736(13)60683-2 ID - Cefalu2013 ER - TY - JOUR AU - Habraken, S. J. M. AU - Sharfo, A. W. M. AU - Buijsen, J. AU - Verbakel, W. F. A. R. AU - Haasbeek, C. J. A. AU - Öllers, M. C. PY - 2017 DA - 2017// TI - The TRENDY multi-center randomized trial on hepatocellular carcinoma—trial QA including automated treatment planning and benchmark-case results JO - Radiother Oncol VL - 125 UR - https://doi.org/10.1016/j.radonc.2017.09.007 DO - 10.1016/j.radonc.2017.09.007 ID - Habraken2017 ER - TY - JOUR AU - Lean, M. E. J. AU - Leslie, W. S. AU - Barnes, A. C. AU - Brosnahan, N. AU - Thom, G. AU - McCombie, L. PY - 2018 DA - 2018// TI - Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(17)33102-1 DO - 10.1016/S0140-6736(17)33102-1 ID - Lean2018 ER - TY - JOUR AU - Remuzzi, G. AU - Macia, M. AU - Ruggenenti, P. PY - 2006 DA - 2006// TI - Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study JO - J Am Soc Nephrol VL - 17 UR - https://doi.org/10.1681/ASN.2005121324 DO - 10.1681/ASN.2005121324 ID - Remuzzi2006 ER - TY - JOUR AU - Rippin, J. AU - Bain, S. C. AU - Barnett, A. H. PY - 2002 DA - 2002// TI - Rationale and design of diabetics exposed to telmisartan and enalapril (DETAIL) study JO - J Diabetes Complications VL - 16 UR - https://doi.org/10.1016/S1056-8727(01)00165-9 DO - 10.1016/S1056-8727(01)00165-9 ID - Rippin2002 ER - TY - JOUR AU - Parving, H. H. AU - Lehnert, H. AU - Bröchner-Mortensen, J. AU - Gomis, R. AU - Andersen, S. AU - Arner, P. PY - 2001 DA - 2001// TI - The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011489 DO - 10.1056/NEJMoa011489 ID - Parving2001 ER - TY - JOUR AU - Patel, A. AU - MacMahon, S. AU - Chalmers, J. AU - Neal, B. AU - Woodward, M. AU - Billot, L. PY - 2007 DA - 2007// TI - Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61303-8 DO - 10.1016/S0140-6736(07)61303-8 ID - Patel2007 ER - TY - JOUR AU - Rodby, R. A. AU - Rohde, R. D. AU - Clarke, W. R. AU - Hunsicker, L. G. AU - Anzalone, D. A. AU - Atkins, R. C. PY - 2000 DA - 2000// TI - The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group JO - Nephrol Dial Transplant VL - 15 UR - https://doi.org/10.1093/ndt/15.4.487 DO - 10.1093/ndt/15.4.487 ID - Rodby2000 ER - TY - JOUR AU - Brennr, B. M. AU - Cooper, M. E. AU - Zeeuw, D. AU - Keane, W. F. AU - Mitch, W. E. AU - Parving, H. H. PY - 2001 DA - 2001// TI - Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011161 DO - 10.1056/NEJMoa011161 ID - Brennr2001 ER - TY - JOUR AU - Shah, D. A. AU - Langenberg, C. AU - Rapsomaniki, E. AU - Denaxas, S. AU - Pujades-Rodriguez, M. AU - Gale, C. P. PY - 2015 DA - 2015// TI - Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1.9 million people JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(15)60401-9 DO - 10.1016/S0140-6736(15)60401-9 ID - Shah2015 ER - TY - JOUR AU - Nichols, G. A. AU - Hillier, T. A. AU - Erbey, J. R. AU - Brown, J. B. PY - 2001 DA - 2001// TI - Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors JO - Diabetes Care VL - 24 UR - https://doi.org/10.2337/diacare.24.9.1614 DO - 10.2337/diacare.24.9.1614 ID - Nichols2001 ER - TY - JOUR AU - Ponikowski, P. AU - Voors, A. A. AU - Anker, S. D. AU - Bueno, H. AU - Cleland, J. G. AU - Coats, A. J. PY - 2016 DA - 2016// TI - 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC JO - Eur J Heart Fail VL - 18 UR - https://doi.org/10.1002/ejhf.592 DO - 10.1002/ejhf.592 ID - Ponikowski2016 ER - TY - JOUR AU - Yancy, C. W. AU - Jessup, M. AU - Bozkurt, B. AU - Butler, J. AU - Casey, D. E. AU - Drazner, M. H. PY - 2013 DA - 2013// TI - 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines JO - Circulation VL - 128 UR - https://doi.org/10.1161/CIR.0b013e31829e8807 DO - 10.1161/CIR.0b013e31829e8807 ID - Yancy2013 ER - TY - JOUR AU - Seferović, P. M. AU - Petrie, M. C. AU - Filippatos, G. S. AU - Anker, S. D. AU - Rosano, G. AU - Bauersachs, J. PY - 2018 DA - 2018// TI - Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology JO - Eur J Heart Fail VL - 20 UR - https://doi.org/10.1002/ejhf.1170 DO - 10.1002/ejhf.1170 ID - Seferović2018 ER - TY - JOUR AU - Dauriz, M. AU - Targher, G. AU - Laroche, C. AU - Temporelli, P. L. AU - Ferrari, R. AU - Anker, S. PY - 2017 DA - 2017// TI - Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc16-2016 DO - 10.2337/dc16-2016 ID - Dauriz2017 ER - TY - JOUR AU - Boonman-de Winter, L. J. AU - Rutten, F. H. AU - Cramer, M. J. AU - Landman, M. J. AU - Liem, A. H. AU - Rutten, G. E. PY - 2012 DA - 2012// TI - High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes JO - Diabetologia VL - 55 UR - https://doi.org/10.1007/s00125-012-2579-0 DO - 10.1007/s00125-012-2579-0 ID - Boonman-de Winter2012 ER - TY - JOUR AU - Seferović, P. e. t. a. r. M. AU - Paulus, W. a. l. t. e. r. J. PY - 2015 DA - 2015// TI - Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes JO - European Heart Journal VL - 36 UR - https://doi.org/10.1093/eurheartj/ehv134 DO - 10.1093/eurheartj/ehv134 ID - Seferović2015 ER - TY - JOUR AU - Poornima, I. G. AU - Parikh, P. AU - Shannon, R. P. PY - 2006 DA - 2006// TI - Diabetic cardiomyopathy: the search for a unifying hypothesis JO - Circ Res VL - 98 UR - https://doi.org/10.1161/01.RES.0000207406.94146.c2 DO - 10.1161/01.RES.0000207406.94146.c2 ID - Poornima2006 ER - TY - JOUR AU - Doehner, W. AU - Frenneaux, M. AU - Anker, S. D. PY - 2014 DA - 2014// TI - Metabolic impairment in heart failure: the myocardial and systemic perspective JO - J Am Coll Cardiol VL - 64 UR - https://doi.org/10.1016/j.jacc.2014.04.083 DO - 10.1016/j.jacc.2014.04.083 ID - Doehner2014 ER - TY - JOUR AU - Heerebeek, L. AU - Hamdani, N. AU - Handoko, M. L. AU - Falcao-Pires, I. AU - Musters, R. J. AU - Kupreishvili, K. PY - 2008 DA - 2008// TI - Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension JO - Circulation VL - 117 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.728550 DO - 10.1161/CIRCULATIONAHA.107.728550 ID - Heerebeek2008 ER - TY - JOUR AU - Falcão-Pires, I. AU - Hamdani, N. AU - Borbély, A. AU - Gavina, C. AU - Schalkwijk, C. G. AU - Velden, J. PY - 2011 DA - 2011// TI - Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.025270 DO - 10.1161/CIRCULATIONAHA.111.025270 ID - Falcão-Pires2011 ER - TY - JOUR AU - Zhang, M. AU - Kho, A. L. AU - Anilkumar, N. AU - Chibber, R. AU - Pagano, P. J. AU - Shah, A. M. PY - 2006 DA - 2006// TI - Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase JO - Circulation VL - 113 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.581397 DO - 10.1161/CIRCULATIONAHA.105.581397 ID - Zhang2006 ER - TY - JOUR AU - Stahrenberg, R. AU - Edelmann, F. AU - Mende, M. AU - Kockskämper, A. AU - Düngen, H. D. AU - Scherer, M. PY - 2010 DA - 2010// TI - Association of glucose metabolism with diastolic function along the diabetic continuum JO - Diabetologia VL - 53 UR - https://doi.org/10.1007/s00125-010-1718-8 DO - 10.1007/s00125-010-1718-8 ID - Stahrenberg2010 ER - TY - JOUR AU - Blomstrand, P. AU - Engvall, M. AU - Festin, K. AU - Lindström, T. AU - Länne, T. AU - Maret, E. PY - 2015 DA - 2015// TI - Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes JO - Eur Heart J Cardiovasc Imaging. VL - 16 ID - Blomstrand2015 ER - TY - JOUR AU - From, A. M. AU - Scott, C. G. AU - Chen, H. H. PY - 2010 DA - 2010// TI - The development of heart failure in patients with diabetes mellitus and preclinical diastolic dysfunction: a population based study JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2009.12.003 DO - 10.1016/j.jacc.2009.12.003 ID - From2010 ER - TY - JOUR AU - Mogelvang, R. AU - Sogaard, P. AU - Pedersen, S. A. AU - Olsen, N. T. AU - Marott, J. L. AU - Schnohr, P. PY - 2009 DA - 2009// TI - Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population JO - Circulation VL - 119 UR - https://doi.org/10.1161/CIRCULATIONAHA.108.793471 DO - 10.1161/CIRCULATIONAHA.108.793471 ID - Mogelvang2009 ER - TY - JOUR AU - Aguilar, D. AU - Deswal, A. AU - Ramasubbu, K. AU - Mann, D. L. AU - Bozkurt, B. PY - 2010 DA - 2010// TI - Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus JO - Am J Cardiol VL - 105 UR - https://doi.org/10.1016/j.amjcard.2009.09.041 DO - 10.1016/j.amjcard.2009.09.041 ID - Aguilar2010 ER - TY - JOUR AU - Ofstad, A. P. AU - Atar, D. AU - Gullestad, L. AU - Langslet, G. AU - Johansen, O. E. PY - 2018 DA - 2018// TI - The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions JO - Heart Fail Rev VL - 23 UR - https://doi.org/10.1007/s10741-018-9685-0 DO - 10.1007/s10741-018-9685-0 ID - Ofstad2018 ER - TY - JOUR AU - Poulsen, M. K. AU - Henriksen, J. E. AU - Dahl, J. AU - Johansen, A. AU - Gerke, O. AU - Vach, W. PY - 2010 DA - 2010// TI - Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease JO - Circ Cardiovasc Imaging VL - 3 UR - https://doi.org/10.1161/CIRCIMAGING.109.855510 DO - 10.1161/CIRCIMAGING.109.855510 ID - Poulsen2010 ER - TY - JOUR AU - Neeland, I. J. AU - Gupta, S. AU - Ayers, C. R. AU - Turer, A. T. AU - Rame, J. E. AU - Das, S. R. PY - 2013 DA - 2013// TI - Relation of regional fat distribution to left ventricular structure and function JO - Circ Cardiovasc Imaging VL - 6 UR - https://doi.org/10.1161/CIRCIMAGING.113.000532 DO - 10.1161/CIRCIMAGING.113.000532 ID - Neeland2013 ER - TY - JOUR AU - Aune, D. AU - Sen, A. AU - Norat, T. AU - Janszky, I. AU - Romundstad, P. AU - Tonstad, S. PY - 2016 DA - 2016// TI - Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose–response meta-analysis of prospective studies JO - Circulation VL - 133 UR - https://doi.org/10.1161/CIRCULATIONAHA.115.016801 DO - 10.1161/CIRCULATIONAHA.115.016801 ID - Aune2016 ER - TY - JOUR AU - Maggioni, A. P. AU - Dahlström, U. AU - Filippatos, G. AU - Chioncel, O. AU - Crespo Leiro, M. AU - Drozdz, J. PY - 2013 DA - 2013// TI - EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) JO - Eur J Heart Fail VL - 15 UR - https://doi.org/10.1093/eurjhf/hft050 DO - 10.1093/eurjhf/hft050 ID - Maggioni2013 ER - TY - JOUR AU - McMurray, J. J. AU - Adamopoulos, S. AU - Anker, S. D. AU - Auricchio, A. AU - Böhm, M. AU - Dickstein, K. PY - 2012 DA - 2012// TI - ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC JO - Eur Heart J VL - 33 UR - https://doi.org/10.1093/eurheartj/ehs104 DO - 10.1093/eurheartj/ehs104 ID - McMurray2012 ER - TY - JOUR AU - Berezin, A. E. PY - 2015 DA - 2015// TI - Cardiovascular biomarkers in routine screening of diabetic patients JO - Clin Med Biochem VL - 2 ID - Berezin2015 ER - TY - JOUR AU - Rich, J. D. AU - Burns, J. AU - Freed, B. H. AU - Maurer, M. S. AU - Burkhoff, D. AU - Shah, S. J. PY - 2018 DA - 2018// TI - Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction JO - J Am Heart Assoc. VL - 7 UR - https://doi.org/10.1161/JAHA.118.009594 DO - 10.1161/JAHA.118.009594 ID - Rich2018 ER - TY - JOUR AU - Roberts, E. AU - Ludman, A. J. AU - Dworzynski, K. AU - Al-Mohammad, A. AU - Cowie, M. R. AU - McMurray, J. J. PY - 2015 DA - 2015// TI - The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting JO - BMJ VL - 350 UR - https://doi.org/10.1136/bmj.h910 DO - 10.1136/bmj.h910 ID - Roberts2015 ER - TY - JOUR AU - Maisel, A. AU - Mueller, C. AU - Adams, K. AU - Anker, S. D. AU - Aspromonte, N. AU - Cleland, J. G. PY - 2008 DA - 2008// TI - State of the art: using natriuretic peptide levels in clinical practice JO - Eur J Heart Fail VL - 10 UR - https://doi.org/10.1016/j.ejheart.2008.07.014 DO - 10.1016/j.ejheart.2008.07.014 ID - Maisel2008 ER - TY - JOUR AU - Copier, C. U. AU - León, L. AU - Fernández, M. AU - Contador, D. AU - Calligaris, S. D. PY - 2017 DA - 2017// TI - Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy JO - Sci Rep. VL - 7 UR - https://doi.org/10.1038/s41598-017-13875-2 DO - 10.1038/s41598-017-13875-2 ID - Copier2017 ER - TY - JOUR AU - Nagueh, S. F. AU - Bhatt, R. AU - Vivo, R. P. AU - Krim, S. R. AU - Sarvari, S. I. AU - Russell, K. PY - 2011 DA - 2011// TI - Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure JO - Circ Cardiovasc Imaging VL - 4 UR - https://doi.org/10.1161/CIRCIMAGING.111.963496 DO - 10.1161/CIRCIMAGING.111.963496 ID - Nagueh2011 ER - TY - JOUR AU - Kirkpatrick, J. N. AU - Vannan, M. A. AU - Narula, J. AU - Lang, R. M. PY - 2007 DA - 2007// TI - Echocardiography in heart failure: applications, utility, and new horizons JO - J Am Coll Cardiol VL - 50 UR - https://doi.org/10.1016/j.jacc.2007.03.048 DO - 10.1016/j.jacc.2007.03.048 ID - Kirkpatrick2007 ER - TY - JOUR AU - Riet, E. E. AU - Hoes, A. W. AU - Limburg, A. AU - Landman, M. A. AU - Hoeven, H. AU - Rutten, F. H. PY - 2014 DA - 2014// TI - Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion JO - Eur J Heart Fail VL - 16 UR - https://doi.org/10.1002/ejhf.110 DO - 10.1002/ejhf.110 ID - Riet2014 ER - TY - JOUR AU - Kelder, J. C. AU - Cramer, M. J. AU - Wijngaarden, J. AU - Tooren, R. AU - Mosterd, A. AU - Moons, K. G. PY - 2011 DA - 2011// TI - The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.019216 DO - 10.1161/CIRCULATIONAHA.111.019216 ID - Kelder2011 ER - TY - JOUR AU - Davie, A. P. AU - Francis, C. M. AU - Love, M. P. AU - Caruana, L. AU - Starkey, I. R. AU - Shaw, T. R. PY - 1996 DA - 1996// TI - Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction JO - BMJ VL - 312 UR - https://doi.org/10.1136/bmj.312.7025.222 DO - 10.1136/bmj.312.7025.222 ID - Davie1996 ER - TY - JOUR AU - Thomas, J. T. AU - Kelly, R. F. AU - Thomas, S. J. AU - Stamos, T. D. AU - Albasha, K. AU - Parrillo, J. E. PY - 2002 DA - 2002// TI - Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure JO - Am J Med VL - 112 UR - https://doi.org/10.1016/S0002-9343(02)01048-3 DO - 10.1016/S0002-9343(02)01048-3 ID - Thomas2002 ER - TY - JOUR AU - Lorenzo-Almorós, A. AU - Tuñón, J. AU - Orejas, M. AU - Cortés, M. AU - Egido, J. AU - Lorenzo, O. PY - 2017 DA - 2017// TI - Diagnostic approaches for diabetic cardiomyopathy JO - Cardiovasc Diabetol VL - 16 ID - Lorenzo-Almorós2017 ER - TY - JOUR AU - Shah, R. V. AU - Abbasi, S. A. AU - Kwong, R. Y. PY - 2014 DA - 2014// TI - Role of cardiac MRI in diabetes JO - Curr Cardiol Rep. VL - 16 UR - https://doi.org/10.1007/s11886-013-0449-0 DO - 10.1007/s11886-013-0449-0 ID - Shah2014 ER - TY - JOUR AU - Bristow, M. R. AU - Kao, D. P. AU - Breathett, K. K. AU - Altman, N. L. AU - Gorcsan, J. AU - Gill, E. A. PY - 2017 DA - 2017// TI - Structural and functional phenotyping of the failing heart: is the left ventricular ejection fraction obsolete? JO - JACC Heart Fail. VL - 5 UR - https://doi.org/10.1016/j.jchf.2017.09.009 DO - 10.1016/j.jchf.2017.09.009 ID - Bristow2017 ER - TY - JOUR AU - Konstam, M. A. AU - Abboud, F. M. PY - 2017 DA - 2017// TI - Ejection fraction: misunderstood and overrated (Changing the Paradigm in Categorizing Heart Failure) JO - Circulation VL - 135 UR - https://doi.org/10.1161/CIRCULATIONAHA.116.025795 DO - 10.1161/CIRCULATIONAHA.116.025795 ID - Konstam2017 ER - TY - JOUR AU - Rosano, G. M. C. AU - Vitale, C. AU - Seferovic, P. PY - 2017 DA - 2017// TI - Heart failure in patients with diabetes mellitus JO - Card Fail Rev. VL - 3 UR - https://doi.org/10.15420/cfr.2016:20:2 DO - 10.15420/cfr.2016:20:2 ID - Rosano2017 ER - TY - JOUR AU - Boonman-de Winter, L. J. AU - Rutten, F. H. AU - Cramer, M. J. AU - Landman, M. J. AU - Zuithoff, N. P. AU - Liem, A. H. PY - 2015 DA - 2015// TI - Efficiently screening heart failure in patients with type 2 diabetes JO - Eur J Heart Fail VL - 17 UR - https://doi.org/10.1002/ejhf.216 DO - 10.1002/ejhf.216 ID - Boonman-de Winter2015 ER - TY - JOUR AU - Das, S. R. AU - Everett, B. M. AU - Birtcher, K. K. AU - Brown, J. M. AU - Cefalu, W. T. AU - Januzzi, J. L. PY - 2018 DA - 2018// TI - 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the american college of cardiology task force on expert consensus decision pathways JO - J Am Coll Cardiol VL - 72 UR - https://doi.org/10.1016/j.jacc.2018.09.020 DO - 10.1016/j.jacc.2018.09.020 ID - Das2018 ER - TY - JOUR AU - Sculpher, M. J. AU - Poole, L. AU - Cleland, J. AU - Drummond, M. AU - Armstrong, P. W. AU - Horowitz, J. D. PY - 2000 DA - 2000// TI - Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group JO - Eur J Heart Fail VL - 2 UR - https://doi.org/10.1016/S1388-9842(00)00122-7 DO - 10.1016/S1388-9842(00)00122-7 ID - Sculpher2000 ER - TY - JOUR AU - Kiernan, M. S. AU - Wentworth, D. AU - Francis, G. AU - Martinez, F. A. AU - Dickstein, K. AU - Komajda, M. PY - 2012 DA - 2012// TI - Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial JO - Eur J Heart Fail VL - 14 UR - https://doi.org/10.1093/eurjhf/hfs145 DO - 10.1093/eurjhf/hfs145 ID - Kiernan2012 ER - TY - JOUR AU - Young, J. B. AU - Dunlap, M. E. AU - Pfeffer, M. A. AU - Probstfield, J. L. AU - Cohen-Solal, A. AU - Dietz, R. PY - 2004 DA - 2004// TI - Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000146819.43235.A9 DO - 10.1161/01.CIR.0000146819.43235.A9 ID - Young2004 ER - TY - JOUR AU - Tsujimoto, T. AU - Sugiyama, T. AU - Kajio, H. PY - 2017 DA - 2017// TI - Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease JO - Diabetes Obes Metab VL - 19 UR - https://doi.org/10.1111/dom.12878 DO - 10.1111/dom.12878 ID - Tsujimoto2017 ER - TY - JOUR AU - Seferovic, J. P. AU - Claggett, B. AU - Seidelmann, S. B. AU - Seely, E. W. AU - Packer, M. AU - Zile, M. R. PY - 2017 DA - 2017// TI - Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post hoc analysis from the PARADIGM-HF trial JO - Lancet Diabetes Endocrinol. VL - 5 UR - https://doi.org/10.1016/S2213-8587(17)30087-6 DO - 10.1016/S2213-8587(17)30087-6 ID - Seferovic2017 ER - TY - JOUR AU - Taylor, A. L. AU - Ziesche, S. AU - Yancy, C. AU - Carson, P. AU - D’Agostino, R. AU - Ferdinand, K. PY - 2004 DA - 2004// TI - Combination of isosorbide dinitrate and hydralazine in blacks with heart failure JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa042934 DO - 10.1056/NEJMoa042934 ID - Taylor2004 ER -